Christian Rommel

Insider Reports History

Entity
Individual
Location
C/O Crispr Therapeutics, 105 West First Street, Boston, MA
Signature
/s/ AJ Silver, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christian Rommel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 26K May 30, 2024 Direct

Insider Reports Filed by Christian Rommel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 0 $0 3 May 30, 2024 Director